HemoSense
Company

Last deal

$7M

Amount

Post-IPO Equity

Stage

12.12.2006

Date

2

all rounds

$7M

Total amount

General

About Company
HemoSense manufactures handheld blood coagulation monitoring systems for the management of warfarin medications.

Industry

Sector :

Subsector :

founded date

01.01.1997

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

The company's INRatio System measures blood clotting time to ensure proper dosage of oral anticoagulant therapy for patients with a propensity to form clots. HemoSense sells its products through distributor partners and operates as a subsidiary of Alere Inc. It was founded in 1997 and is based in San Jose, California.
Contacts